Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03335917 · ClinicalTrials.gov registry record · NA
Oxygen Transport in Normobaric vs. Hypobaric Hypoxia
A NA study, sponsored by University of Nebraska.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT03335917 is a NA study that has completed, run by University of Nebraska. The registered enrollment target is 12 participants.
The verdict
NCT03335917, a NA study, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
1\) Oxygen Transport in Normobaric versus Hypobaric Hypoxia. 2) The purpose of this study is to examine acute responses in arterial and muscle tissue oxygenation during incremental exercise in normobaric versus hypobaric hypoxia. 3) The participants in this study will consist of 12 recreationally active males and females between the ages of 19 and 45.Recreationally active is defined as participating in moderate to vigorous physical activity for 30 minutes at least 3 days per week.4) Subjects will complete an incremental cycle test to volitional fatigue in three conditions in a randomized counter-balanced order, normobaric normoxia (20.9% O2, 730 mmHg), normobaric hypoxia (14.3% O2, 730 mmHg) and hypobaric hypoxia (20.9% O2, 530mmHg). Two of the three trials will be conducted in an environmental chamber to simulate normobaric normoxia at 350 m (elevation of Omaha, NE) and normobaric hypoxia at 3094 m (elevation of Leadville, CO). The hypobaric hypoxia trial will be conducted in Leadville, Colorado at 3094 m. Trials will be separated by at least two days. Rating of perceived exertion, heart rate, blood oxygenation, respiration rate, muscle tissue oxygenation, and whole body gases will be analyzed during the trials. 5) There is no follow-up as a part of this study.
Interventions
- OTHER Exercise
- OTHER Hypoxia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2017-08-15 |
| Est. Completion | 2018-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03335917
The ClinicalTrials.gov registry entry for NCT03335917 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Exercise is the first listed.
NCT03335917 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03335917 about?
NCT03335917 is a clinical study titled "Oxygen Transport in Normobaric vs. Hypobaric Hypoxia". 1\) Oxygen Transport in Normobaric versus Hypobaric Hypoxia. 2) The purpose of this study is to examine acute responses in arterial and muscle tissue oxygenation during incremental exercise in normobaric versus hypobaric hypoxia. 3) The participants in this study will consist of 12 recreationally ac...
What is the current status of trial NCT03335917?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2017-08-15. Estimated completion is 2018-06-01.
What interventions are being tested in trial NCT03335917?
The interventions under investigation include: Exercise (OTHER), Hypoxia (OTHER).
Who is sponsoring clinical trial NCT03335917?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.